Rodrigo Ortiz

A gene therapy may begin with an elegant idea: deliver a genetic instruction to the right cells and change how they behave. Yet between that idea and a treatment lies an enormous manufacturing challenge. ...

What if scientists could control the activity of cells using nothing more than pulses of light? What sounds like science fiction has become one of the most influential technologies in modern biology. Earlier this ...

For families affected by a rare and ultra-rare genetic disorder, the distance between a promising laboratory result and an accessible treatment can feel impossibly large. Developing a gene therapy requires much more than identifying ...

Every cell in the human body contains essentially the same genetic instructions, yet a heart cell behaves very differently from a nerve or skin cell. For many years, scientists assumed that once a cell ...

Cancer treatment has undergone a remarkable transformation over the past decade. What if, instead of relying solely on drugs to attack tumors, we could reprogram a patient's own immune cells to seek out and ...

CRISPR technologies can rewrite a disease-causing DNA sequence, switch a gene off, correct a single genetic letter or even alter gene activity without changing the underlying DNA. Yet a genome editor can only work ...

What if one of the biggest obstacles in gene therapy could be solved by borrowing a concept from everyday life? Just as Velcro joins two separate pieces together to create a strong and functional ...

How does a breakthrough gene therapy begin? What does it take to turn a scientific idea into a treatment that can reach a patient? In this interview, Duško Lainšček, researcher at the Institute of Chemistry ...

The CTGCT was represented at the GMP Symposium 2026, held in Tuheljske Toplice, where leading experts gathered to exchange knowledge and practical experiences in GMP environments. As part of the scientific program, our head Dr. ...

On the 2nd of June 2026, the GeneH Consortium met together in Ljubljana for their yearly meeting and on the 3rd the consortium organized together with the Center for Functional Genomics and BioChips (CFGBC), ...

At the ASGCT 2026 Annual Meeting in Boston (May 11–15, 2026), held held in Boston, Massachusetts, USA, our colleague Dr. Duško Lainšček presented two pieces of work that reflect this translational reality. One of ...